2016 - Cancer Currents Blog
-
Research from TARGET, an NCI-funded program supporting genomic analyses of childhood cancers, has led to the launch of several clinical trials of targeted therapies to treat children with acute lymphoblastic leukemia.
-
Two new studies suggest that a new class of drugs can effectively target a molecular driver of the most common type of kidney cancer.
-
Many family members who care for loved ones with cancer do not feel adequately prepared for the caregiving tasks they assume and need help to make informed decisions about end-of-life care, according to a new study.
-
A new study suggests that a chromosomal instability score may help guide treatment choices for patients with cancer.
-
NCI and NIH announce efforts to establish international collaborations that can accelerate progress in reducing the global cancer burden.
-
NCI’s new application programming interface (API) that allows anyone to build online tools that help people find NCI-supported clinical trials.
-
The Impact and Future of the Childhood Cancer Survivor Study: An Interview with Greg Armstrong, M.D.Dr. Greg Armstrong of the Childhood Cancer Survivor Study discusses this long-running study and its future.
-
Pancreatic cancer cells instruct healthy cells around them to provide nutrients they need to survive and grow, a new study suggests.
-
NCI Acting Director Dr. Douglas R. Lowy, M.D., thanks the cancer community for contributing to the Cancer Moonshot Blue Ribbon Panel report, which was presented to the National Cancer Advisory Board on September 7.
-
In a recent study, researchers showed that a new approach may provide a safer way to perform stem cell transplants for treating cancer and other diseases.